Sort
11,323 grants matching “glioblastoma”
Understanding the role of O-GlcNAcylation in regulating cancer lipid metabolism
$29,280Valerie Sodi Salvatico · Drexel University · F31 · FY2016 · CA
Therapeutics Studies of Primary CNS Malignancies
$29,138Patrick Y Wen · Dana-Farber Cancer Inst · U01 · FY2006 · CA
Refinement of CAR-T-Cell therapy targeting glioblastomas
$29,016Dongrui Wang · Beckman Research Institute/City Of Hope · F99 · FY2019 · CA
Improving CNS Delivery of Chemotherapeutic to Invasive Brain Cancer
$28,982Nathan Roberts · University Of Maryland Baltimore · F30 · FY2020 · CA
Developing Pharmacological tGLI1 Inhibitors
$28,965Daniel Doheny · Wake Forest University Health Sciences · F31 · FY2022 · CA
Targeting TCA cycle in Brain Tumor Initiating Cells
$28,849Jin Young Leo Kim · Case Western Reserve University · F30 · FY2017 · CA
Functional role of Ascl1 in the developing spinal cord
$28,837Mark Borromeo · Ut Southwestern Medical Center · F31 · FY2011 · NS
The Role of CD147 in Glioblastoma Invasiveness
$28,827Nicholas Colangelo · Rbhs-New Jersey Medical School · F30 · FY2020 · CA
The Unfolded Protein Response in Glioblastoma
$28,824Briana Prager · Case Western Reserve University · F30 · FY2017 · CA
Targeted nano-boron based boron neutron capture therapy for glioma treatment
$28,736Rameshwar Tukaram Patil · Cedars-Sinai Medical Center · R21 · FY2022 · CA
Proteasomal regulation of BMI-1 and impact on tumor initiating cells in glioblastoma
$28,473Michele Patrizii · Rbhs -Cancer Institute Of New Jersey · F31 · FY2018 · CA
Program 11 Cancer Immunology
$28,431Arlene H Sharpe · Dana-Farber Cancer Inst · P30 · FY2023 · CA
Program 11 Cancer Immunology
$28,410Arlene H Sharpe · Dana-Farber Cancer Inst · P30 · FY2022 · CA
Overcoming Inferior Quality of Vaccine Responses After Alkylating Chemotherapy
$28,410Adam Jacob Litterman · University Of Minnesota · F31 · FY2013 · CA
Cadherin Regulation of Glioma Invasion: A Biophysical Perspective
$28,393Joseph Chen · University Of California Berkeley · F32 · FY2019 · CA
Analytical Immunopharmacology
$28,346Timothy W Synold · Beckman Research Institute/City Of Hope · U19 · FY2022 · CA
Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model
$28,281Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
Functional role of Ascl1 in the developing spinal cord
$28,272Mark Borromeo · Ut Southwestern Medical Center · F31 · FY2010 · NS
Consequences of metabolic reprogramming by GLUT3 in GBM
$28,225Catherine J Libby · University Of Alabama At Birmingham · F31 · FY2019 · NS
Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Gliobastoma
$28,158Sara Marie Francis-Reed · University Of Iowa · F30 · FY2012 · CA
Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Glioblastoma
$28,158Sara Marie Francis-Reed · University Of Iowa · F30 · FY2013 · CA
Towards a spatial view of Ras signaling and immune cell function in NF-1 mutant glioblastoma
$28,077Maryam Pourmaleki · Weill Medical Coll Of Cornell Univ · F31 · FY2023 · CA
GEN - Project
$27,846P. Todd Stukenberg · University Of Virginia · P30 · FY2024 · CA
GEN - Project
$27,846P. Todd Stukenberg · University Of Virginia · P30 · FY2025 · CA
GEN - Project
$27,843P. Todd Stukenberg · University Of Virginia · P30 · FY2023 · CA